JAZZ - Why GW Pharmaceuticals Stock Rocketed 40.5% in February
Shares of GW Pharmaceuticals (NASDAQ: GWPH) rose 40.5% in February, according to data provided by S&P Global Market Intelligence . The bulk of the move came on Feb. 3 when Jazz Pharmaceuticals (NASDAQ: JAZZ) announced it would be purchasing GW for $7.2 billion, or the equivalent of $220 per share, made up of $200 per share in cash and $20 in Jazz stock.
GW also reported its fourth-quarter and full-year results during the month.
Image source: Getty Images.
For further details see:
Why GW Pharmaceuticals Stock Rocketed 40.5% in February